trust me.....okay i am in this business
700,000 every year are effected by UC
uceris @ 30% = 210K x $1403 = $300M
uceris @ 50% = $500M
right now they took only 50,000 from 700,000 for the year 2013
Can someone give revenue estimates for Rifamycin ? Is it suppose to be blockbuster drug ? travelers diarrhea doesn't seem to be like huge market.
Do you use some sort of software for indications ? please elucidate.
Sentiment: Strong Buy
On the downside, Santarus (SNTS) dropped 5% in more than double its average daily volume. The drugmaker is now 10% below a 24.10 buy point, triggering IBD's 8% sell rule. The stock had been as much as 17% above the entry.